SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by ChromaDex Corporation (CDXC) on June 27, 2019, reporting events from its 2019 Annual Meeting of Stockholders held on June 21, 2019. The registrant is incorporated in Delaware and trades on the Nasdaq Capital Market. Note: The input metadata referenced "Niagen Bioscience, Inc.," but the filing text explicitly identifies the registrant as ChromaDex Corporation.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The filing details the outcomes of two proposals submitted to stockholders:
- Proposal 1 (Election of Directors): All eight nominees were elected to serve until the 2020 Annual Meeting. Significant broker non-votes (17,914,456 shares) were recorded for all candidates.
- Frank L. Jaksch Jr.: 27,936,498 For; 84,697 Withheld.
- Stephen Block: 26,861,044 For; 1,160,151 Withheld.
- Jeff Baxter: 27,220,631 For; 800,564 Withheld.
- Robert Fried: 27,293,665 For; 727,530 Withheld.
- Kurt Gustafson: 26,510,137 For; 1,511,058 Withheld.
- Steven Rubin: 25,196,943 For; 2,824,252 Withheld.
- Wendy Yu: 27,924,203 For; 96,992 Withheld.
- Tony Lau: 26,944,779 For; 1,076,416 Withheld.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- For: 45,234,412
- Against: 416,981
- Abstain: 284,258
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, risk factors, or contingencies beyond the standard disclosure of voting results.
Key Facts for Investor Verification
- Verify the correct registrant name is ChromaDex Corporation, not Niagen Bioscience, Inc.
- Confirm the high volume of broker non-votes (approx. 17.9 million shares) regarding director elections, which may indicate significant institutional holdings where brokers lacked discretionary voting power.
- Review the full proxy statement for details on director qualifications and the rationale for the auditor ratification.
- Check subsequent filings for the company's actual financial performance, as this 8-K contains no financial data.